chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received the Hib, MMR, and DRaP on August 27, 2007.  On August 30, patient had a high fever (102F) and vomited.  Later that evening, he had his first seizure.  On August 31, patient had a seizure that lasted longer that 1 minute, and we took him to the emergency room.  He did not have a fever when he entered the emergency facility.  He had another seizure at the hospital, and was diagnosed with a seizure disorder and sent home.  Through the night on August 31 he had numerous seizures, and was taken to Hospital.  He was admitted.  He was delirious, signing and saying words that were inappropriate.   (for him, I know he was 1 but his language, and signing, at the time were very advanced).  He was tested for encephalitis.  The ER doc continued to say that it looked like patient had Hib.  And he continued to ask us if we'd vaccinated patient.  (ignoring the comments that we'd vaccinated patient just 6 days prior)  Eventually patient's seizures were stopped on Sept 2.  He remains on Keppra, and is tolerating it, but has lost much of his verbal skills.  While he was diagnosed with viral encephalitis -- endero virus, his seizures and illnes were more severe than would normally be seen with endero virus. 12/31/07-records received for DOS 9/1-9/4/07-DC DX: Enterovirus encephalitis. Seizures due to #1.  Became ill morning prior to admission developed fever and seizure. Temperature since onset has been 102. Has had 6-8 seizures lasting less than a minute and resolving spontaneously. Left ward deviation of both eyes, stiffening of all 4 extremities and clenching of jaw, followed by extreme somnolence. 01/10/2010 Still has abnormal EEG that suggests segeuls. Still on keppra 01/19/2010 Still as EEG that indicates Epileptic activity. Has had minor sequel activity. Continues to take Keppra is still showing language delay.
After getting the first and second dose , the next day I started having sinus bleeds with tiny clots, it lasts for several days, I want to say 4-5 days .
12FEB91 @ ER PT had edema of rt arm, pain & limitation of movements; given ATBs & acetaminophen; 14FEB PT had pain, redness & hyperthermia of rt arm & elbow; dx cellulitis p/vax vs. septic arthritis; cont on oral ATBs to complete 10 day rx;
Information has been received from a licensed practical nurse concerning an unspecified number of patients of unknown age and gender. The patients' concomitant medications, pertinent medical history, and drug reactions and allergies have not been provided.      From November 2016 to 23-FEB-2017, improperly stored doses of VARIVAX (dose, strength, frequency and route were unknown, lot # L015048, expiration date 29-APR-2017) were each administered to the unspecified patients for immunization. The VARIVAX was exposed -4.3 Celsius for a time frame of 1 hour 18 minutes. The previous temperature excursions of the VARIVAX are a range between -10 Celsius and 8 Celsius in 10 hours 40 minutes and a range between -15 Celsius and -10 Celsius  in 3 hour 59 minutes. A data logger was in use. No adverse effects were reported. This is one of several reports from the same reporter. Additional information has been requested.  ; Sender's Comments: US-009507513-1703USA003154:
ED NOTES 11/15/21: He notes he has had intermittent fever for the past 5 days, along with nonproductive cough.  Was vaccinated with the J and J COVID-19 vaccination however this was in March.  Has not yet received his booster shot.  Today he notes some mild chest pain and mild shortness of breath, given his fever and cough and these new symptoms of chest pain shortness of breath is recommended he come in for further evaluation.  He notes some mild chills as well.
Heartbeat 110 at rest. Overall body aches. Extreme fatigue starting about 12 hrs after injection and lasting about 48 hrs. Passed out in shower about 29 hrs after injection.  (Have no history of fainting.)
Information has been received from a 69 year old male with no medical history or allergies who on 16-DEC-2007 was vaccinated with a 0.5 ml dose of ZOSTAVAX (Oka/Merck). Concomitant therapy included IMITREX and PREVACID. On 17-DEC-2007 the patient experienced pain at injection in his arm. The pain eventually moved to the patient's other arm. Unspecified medical attention was sought. No diagnostic laboratory tests were undertaken. At the time of report the patient had not recovered. A product quality complaint was not involved. Additional information has been requested.
My mother complained of chest pressure and shortness of breath breath while at work  numerous times to her co-workers. Her fellow employees reported having her sit down until she said she was feeling better. The very next day she did a short 4 hour shift at work came home and was found dead by her husband in the front yard of her home.
This spontaneous report was received from a medical assistant refers to patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On 17-AUG-2016, the patient was inadvertently vaccinated with a dose of VARIVAX lot # M009765, expiry date 23-FEB-2018 and a dose of PROQUAD lot # M012985, expiry date 12-SEP-2017 on different unspecified arms (dose, strength, dose number, vaccination site, route not provided). Product quality complaint (PQC) was not involved. No adverse effects were reported. Additional information has been requested.
Great pain; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Great pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Great pain). At the time of the report, MYALGIA (Great pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information provided. No treatment information given.
Patient presented with some slight redness and raised area on her injection site on 10/6/22. Slight pain to the touch. Later evening on 10/6/22 patient reported the site is warm to the touch and redness is increasing. Patient describes a reaction similar to this 2 years ago.
She said that the onset of the symptoms was 2-3 hours after the vaccination, and 4 hours later she developed some allergic reaction and hives (  at the temple). Other symptoms were loss of equilibrium, chills and pain in the back of the head at the nape of the neck, also low grade fever 37.5°C.  She had a HTN 180/90 mmHg, but she has a history of HTN and currently is taking Enalapril 10 mg/ day. She is taking also some supplements Vit C and vitamin D but not constantly, that day she did not take it. She woke up during the night and took the medication for high blood pressure, the next day the blood pressure normalized. She is allergic to  some foods, for example strawberries , propolis and some of the anti-inflammatories such us Ibuprofen. Took an antiallergic  in the evening ? Xyzal- 1tab.
TOOK THE FIRST DOSE WITH A MEAL; This spontaneous case report (PVX2019-2153, PVX2019-2154) was received from a pharmacist on 22-Aug-2019. It described a 60-year-old female consumer who "took the first dose with a meal" (PT: Product administration error), while being on oral Vivotif (one dose every other day) for typhoid fever prophylaxis.  Case report: The consumer took the first dose of Vivotif with a meal on 22-Aug-2019. It was reported that she was planning on getting new doses to complete the course of Vivotif.  Action taken with Vivotif was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "took the first dose with a meal" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took the first dose with a meal" was considered as not applicable.
Patient became dizzy about 5-10 minutes after getting vaccinated. He fell and hit his head. Then lost consciousness and 2 courses of CPR helped revive him..
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment medication was reported.   This case was linked to MOD-2021-038277 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Updated Patient demographics, and outcome of the event; Sender's Comments:  MOD-2021-038277:
itching sensation; rash on her body; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 81-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: unknown), via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date patient experienced itching sensation, rash on her body it was reported that patient received the second dose of the COVID-19 vaccine a month ago and for 4 days now the patient experienced itching sensation and rash on her body, she had to put alcohol on her skin and take showers to get rid off the itching. The patient visited the physician office for the events. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pt recvd 1st dose of Hep B vax on 14MAY91 w/no adverse rxn; On 14JUN91 pt recvd 2nd dose of Hep B; On same day of vax pt devel fever, fatigue, achiness, dec appetitie, rhinitis, cough, & soreness @ inject site; pt seen in ER & treated;
ended up W/some terrible virus anyway; Initial information was received on 30-Nov-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-health-care professional.  This case involves an unknown age and gender patient who stated ended up w/some terrible virus anyway while receiving vaccine influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received an unknown dose of suspect influenza vaccine produced by unknown manufacturer (lot number, expiry date, strength, frequency was unknown) via unknown route in unknown administration to be used for Influenza immunization.  On an unknown date the patient had a non-serious ended up w/some terrible virus anyway (viral infection) (unknown latency) following the administration of influenza vaccine.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.
On February 24 and 25 and 26 my hands and feet swelled on the 27th my left hand turned purple and very inflamed
Beginning November 23, I began breaking out in itchy hives on various parts of my body (neck, ankles, back, torso, legs, pelvic area.  On November 24, I experienced dull stomach pain strong enough to make walking around in normal activities difficult, which continued until Nov 25.  After a medical visit to a nurse practitioner  on November 29, I  was told to take a 24-hour antihistamine.  I took Cetirizine hydrochloride (10 mg) for a week, with a single dose of Benadryl on the first night (as instructed).  The Cetirizine hydorchloride was effective, but the hives returned within 36 hours after discontinuing, and intensified after an additional  without medication.  They responded to a new dose of Cetirizine hydrochloride.  The hives continue throughout the day, but individual areas of hives come and go.  I am not aware of being allergic to anything, other than the contact dermatitis I get from lotions, which presents very differently (in a rash and blisters).
persistent rash that changes locations; This is a spontaneous report from a contactable consumer. A adult non-pregnant female patient of unspecified age received bnt162b2 ((PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection) via an unspecified route of administration on Jun2021 (Batch/Lot number: Not provided) as dose number unknown, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown, Prior to vaccination, the patient diagnosed with COVID-19. Since the vaccination, patient did not test for COVID-19. The patient experienced persistent rash that changes locations on an unspecified date in Jun2021. Patient visited the physician office for the event. Patient did not receive any treatment for the event. The event was not serious, no life threatening, no prolonged hospitalization, no disabling and no Congenital anomaly/birth defect. Outcome of event was not recovered.   The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts are completed. No further information is expected.
Patient's mother noticed redness at injection site approximately 24 hours after injection. Reddened area spreading out from site approximately 2cm x 5cm. Afebrile temp: 98.6 ear. Raised red area tender to touch.
Cardiac event - Elevated heart enzymes, inflamed heart, chills, inability to move neck, joint pain, pulsating fingers, pain in arms, fatigue, shortness of breath, pain in heart.   Hospitalized July 2 to July 4
On Thursday following my vaccine, I woke up with fever and chills.  Fever was 101 and was relieved with Advil.  On Friday, I woke up in the morning and my lymph node under my left arm was swollen like a grapefruit.  Was swollen for approximately 4 days.
Full body aches for 24 hours Headache lasting more than 24 hours Nausea for 24 hours
Dry mouth; sore arm; redness; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (Dry mouth), PAIN IN EXTREMITY (sore arm) and ERYTHEMA (redness) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included GABAPENTIN for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced DRY MOUTH (Dry mouth), PAIN IN EXTREMITY (sore arm) and ERYTHEMA (redness). At the time of the report, DRY MOUTH (Dry mouth), PAIN IN EXTREMITY (sore arm) and ERYTHEMA (redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For treatment, patient used over the counter muscle rub and some biotin contain wash for topical use.
Left Arm swollen , red from injection site to elbow and above and around arm. left arm sore to touch and hot Chills, head ache digustion problems. left arm hard to touch
12 days after COVID vaccine, patient had episode of syncope, preceded by dizziness and confusion.
vomiting/Fever chills  shakes  1/27/2021- Vomited 3 times --went to ED Covid negative
Hives; Rash; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives) and RASH (Rash) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 031L20A) for COVID-19 vaccination.     Concomitant products included PANTOPRAZOLE for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives) and RASH (Rash). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) at an unspecified dose and frequency. At the time of the report, URTICARIA (Hives) and RASH (Rash) had not resolved.
Soreness woke her up between 12  and 1 am couldn't lift arm on Tuesday. Couldn't get of bed Wednesday. Chills. fever. Lymph Node swelling started 4/14/2021. Extreme fatigue
This spontaneous report was received from a pharmacist, concerning a patient of an unknown age and gender. There were no concurrent conditions, medical history, drug reactions or allergies or concomitant medications reported. On 15-FEB-2017, the patient was vaccinated with an expired dose of ZOSTAVAX vial 19400 PFU (0.65 ml once, subcutaneously), lot # L016283 with expiration date of 07-AUG-2016, for prophyalxis. No adverse effects were reported. No product quality complaint was involved (PQC). Additional information has been requested.
Narrative: admitted for pneumonia and hypoxia; died from multiorgan failure; h/o alzheimers
- standard COVID-19 vaccine side effects started on day of vaccination and consisted of fatigue, body aches, and nausea. fatigue and body aches are still present and are being treated with acetaminophen. - sore throat started on 05.09.2021 and is still present. treatment consists of acetaminophen and rest.
Severe body aches and 99.7 degree fever. Advil helped, however continue to have body aches, and fever, with need to take ibuprofen every 8 to 10 hours.
Pt. called pharmacy to report itching, rash on opposite arm of administration 7/14/12, Pt. told to take BENADRYL and call her MD. 7/15/12 pt. called to report she's under MD. care - paged MD & her throat feels swollen & is painful.
Information has been received from a nurse concerning an 18 month old male who in January 2004, was vaccinated subcutaneously with 0.5 ml dose of varicella virus vaccine live.  The nurse reported that in 2004 the patient developed 2 big lesions on his trunk and several small ones.  The patient was noted to be afebrile.  Unspecified medical attention was sought, but no treatment was required.  At the time of this report, the outcome was unknown.  Additional information has been requested.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): NUS2022US037321_NC (Novartis).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunization. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "Tired".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
CHILLS, FEVER, REDNESS AND PAIN AT INJ SITE; ITCHING AT INJ SITE; COUGH; SOB; UPPER RESPIRATORY SYMPTOMS; DIARRHEA TOOK IBUPROFEN, DAYQUIL; NYQUIL TO TREAT SYMPTOMS.
No adverse effects reports- instructed by Dept Health to fill out VAERS since individual under 18 received Moderna vaccine.
Covid-19 vaccination administered 01/08/2021. Developed redness to LT upper arm on 1/17/21. Noted area of ecchymosis to LT upper arm and forearm on 1/18/21. Seen in clinic on 1/18/21. L upper arm there is a 7x6 cm area of red minimally raised area in the deltoid with increased warmth. There is an other area of redness in the Biceps  12x5cm .All these areas are surrounded by Ecchymosis. The Ecchymosis is extending to the lateral Flexor aspect of the forearm. Non tender. DX: Cellulitis.  Duricef and warm compresses. Return to clinic in five days for re-evaluation.
No additional AEs were reported; The nurse reported that 33 patients received improperly stored vaccines.; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported.  On 11-MAR-2022, the patient was vaccinated with an improperly stored of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) for prophylaxis (lot # U026217 has been verified to be a valid lot number haemophilus b conjugate vaccine (meningococcal protein conjugate), expiration date reported and establish as 02-NOV-2023) (strength, dose, route of administration and anatomical location were not provided).  The temperature of storage and time frame of the excursion were 34.3° Fahrenheit (C) for 55 minutes respectively.  If a digital data logger was involved was not reported.  The vaccines did not experience a previous temperature excursion.  No adverse event reported.   This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2204USA001821: US-009507513-2204USA001816: US-009507513-2204USA001791:
Peripheral numbness feet, legs; tingling in hands; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 2, single (Lot number: EN6200), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Pancreatic cancer" (unspecified if ongoing); "Shellfish" (unspecified if ongoing). Concomitant medication(s) included: CALCIUM; VIT D3; ASPIRIN [ACETYLSALICYLIC ACID]; PANTOPRAZOLE. Vaccination history included: Bnt162b2 (lot number=EL9261, Other vaccine same date vaccine date=20May2022, dose 1, single, location=Right arm.), for Covid-19 Immunization, reaction(s): "Peripheral numbness feet, legs", "tingling in hands". The following information was reported: HYPOAESTHESIA (non-serious), outcome "unknown", described as "Peripheral numbness feet, legs"; PARAESTHESIA (non-serious), outcome "unknown", described as "tingling in hands".  Additional information: Peripheral numbness feet, legs and tingling in hands. Started after first dose but didn't equate it with vaccine until after the most recent booster. Initially in left foot/leg only about two three weeks after shot. A week after the 4th booster my right foot/leg and fingers were affected and right leg worse. Then connected the dots from beginning.  No follow-up attempts are possible. No further information is expected.
Proliferative diabetic retinopathy; Peripheral visual field defect of both eyes; Optic neuropathy; ischemic Optic neuropathy; This case was reported by a lawyer and described the occurrence of ischemic optic neuropathy in a patient who received Herpes zoster (Shingrix) for prophylaxis.  The initial information was received on 27 May 2021 via medical record (case is now medically confirmed). Plaintiff current condition includes Tobacco use disorder. As per the medical records plaintiff had received Shingrix on 14 August 2018 for Prophylaxis. Patient was diagnosed with Optic neuropathy and Ischemic Optic neuropathy on 21 March 2019, Peripheral visual field defect of both eyes on 02 April 2019 and Proliferative diabetic retinopathy on 06 May 2019
Pt received Moderna #1 on 3/1/202 Pt received Moderna #2 on 3/29/2021 Pt reported on 4/6/2021 that she experienced lip swelling after both vaccines- no other sxs  Pt had not reported sxs before 4/6/2021 Pt reported sxs by phone was not examined Did not have appt